Post-approval studies (Phase 4)UnknownNCT00949351
What this trial is testing
Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy
Who this might be right for
Type 2 Diabetes With Nephropathy
Lerdsin General Hospital 80